3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
7
Radiotherapy
4
Mitomycin
3
Epirubicin
2
toripalimab
1
tislelizumab
1
pirarubicin
1
hydroxycamptothecinum
1
Maintenance
1
Injections
1
Docetaxel
1
BCG Vaccine
1
Anesthesia, Spinal
1
Anesthesia, General
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Non-Muscle Invasive Bladder Neoplasms
×
Maintenance
×
Clear all
NCT07207824
2025-10-06
HERO
Fudan University
Phase 3
Not yet recruiting
182 enrolled